A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks-Reference-Cited by-同舟云学术

A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks

Published:2016-12-07 Issue:2 Volume:13 Page:266-270
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Shukarev Georgi¹,Callendret Benoit²,Luhn Kerstin²,Douoguih Macaya²,

Affiliation:

1. Janssen Vaccines AG, Bern, Switzerland

2. Janssen Vaccines & Prevention B.V., Leiden, The Netherlands

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2017.1264755

Reference20 articles.

1. Virus Taxonomy – San Diego 1998

2. Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic Review

3. Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control

4. Investigating the zoonotic origin of the West African Ebola epidemic

5. WHO’s to blame? The World Health Organization and the 2014 Ebola outbreak in West Africa

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Immunogenicity of an Accelerated Ebola Vaccination Schedule in People with and without Human Immunodeficiency Virus: A Randomized Clinical Trial;Vaccines;2024-05-04

2. Safety and Immunogenicity of Accelerated Heterologous 2-Dose Ebola Vaccine Regimens in Adults With and Without Human Immunodeficiency Virus in Africa;Clinical Infectious Diseases;2024-04-24

3. Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda;Vaccine;2024-04

4. Bayesian inference for prediction of survival probability in prime‐boost vaccination regimes;Statistics in Medicine;2023-12-18

5. Evaluation of immunogenicity-induced DNA vaccines against different SARS-CoV-2 variants;PLOS ONE;2023-12-07